| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.78▼ | 5.77▼ | 5.78▼ | 5.80▲ | 5.88▼ |
| MA10 | 5.78▼ | 5.79▼ | 5.76▼ | 5.90▼ | 6.11▼ |
| MA20 | 5.79▼ | 5.81▼ | 5.83▼ | 5.92▼ | 6.44▼ |
| MA50 | 5.82▼ | 5.91▼ | 5.91▼ | 6.28▼ | 6.68▼ |
| MA100 | 5.89▼ | 5.92▼ | 5.93▼ | 6.50▼ | 6.55▼ |
| MA200 | 6.00▼ | 6.34▼ | 6.38▼ | 6.76▼ | 6.29▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.001▲ | -0.002▼ | 0.002▲ | -0.073▼ |
| RSI | 34.040▼ | 40.956▼ | 42.195▼ | 45.780▼ | 42.402▼ |
| STOCH | 30.556 | 41.250 | 53.620 | 30.288 | 14.992▼ |
| WILL %R | -100.000▼ | -62.500 | -75.410▼ | -59.524 | -84.615▼ |
| CCI | -292.212▼ | -79.292 | -81.614 | -65.976 | -78.505 |
|
Monday, March 30, 2026 08:17 AM
Appointment underscores Champions' focus on leveraging clinically relevant data to power next-generation oncology R&D HACKENSACK, NJ / ACCESS Newswire / March 30, 2026 /Champions Oncology, Inc.
|
|
Monday, March 30, 2026 08:14 AM
Appointment underscores Champions' focus on leveraging clinically relevant data to power next-generation oncology R&D HACKENSACK, NJ / ACCESS Newswire / March 30, 2026 / Champions Oncology, Inc. (Nasd ...
|
|
Thursday, March 19, 2026 05:19 AM
Despite a slight dip in total revenue, Champions Oncology Inc (CSBR) showcases strong operational performance with record core study revenue and strategic growth investments.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/03/26 | 5.70 | 5.9189 | 5.70 | 5.84 | 7,101 |
| 27/03/26 | 5.82 | 5.9015 | 5.65 | 5.74 | 11,340 |
| 26/03/26 | 5.80 | 5.845 | 5.745 | 5.79 | 8,098 |
| 25/03/26 | 5.825 | 5.875 | 5.80 | 5.80 | 7,291 |
| 24/03/26 | 5.81 | 5.9651 | 5.80 | 5.81 | 44,300 |
| 23/03/26 | 6.095 | 6.10 | 5.8041 | 5.96 | 3,324 |
| 20/03/26 | 6.21 | 6.2131 | 5.86 | 5.86 | 4,267 |
| 19/03/26 | 5.96 | 6.20 | 5.8413 | 6.20 | 18,812 |
| 18/03/26 | 6.1646 | 6.1646 | 5.83 | 5.83 | 16,782 |
| 17/03/26 | 6.13 | 6.34 | 6.13 | 6.20 | 3,099 |
|
|
||||
|
|
||||
|
|